Kachnar - Tasty buds

Make any dish an exotic one

Medicines Pool Swirls

Drug companies are slowly joining the UN effort to offer life-saving patented medicines to poor countries but the terms are sometimes restrictive

Getting the drug equation right

Sonal Matharu reports how fights over counterfeit drugs and low-quality drugs is suppressing the larger issue of drug safety

Obama takes first dip

The US becomes the first to join a global patents pool to make AIDS drugs cheaper but health workers are sceptical of the initiative

ACTA fury goes viral

Europe is on the boil over an anti-piracy bill that will curb Internet freedom but its impact on trade in generic medicines is not on the radar

Predatory EU pacts

EU is pushing India and Canada to sign free trade agreements that will hurt their generic drugs—and the outrage is global

Parliamentary panel recommends price cap for all drugs

Money spent in importing medicines a big concern for government

External threat

Effective oral drug for Hepatitis C approved by European agencies

Various patent barriers hinder its availability and affordability, especially in countries with high burden of disease

Profits and not improving accessibility matter to Indian drug makers

FICCI conference organised to discuss access to generic medicines focuses more on increasing exports

AAP promises to improve health set-up and promote generic medicines in Delhi

Party says it will address health concerns of both the elderly and the young if it is voted to power

Mission health for all

What prime minister needs to do to make good his promise on making 12th Five-Year Plan a health plan

US authority approves more efficacious hepatitis C drug

Sofosbuvir's prohibitive cost will put it out of reach of most patients in developing countries, including India

Ranbaxy launches new anti-malarial drug

It has an efficacy rate of over 95 per cent, claims company

Indian company gets licence to manufacture and sell patented cancer drug

This is the first-ever compulsory licence given to a generic drug company

Bytes

Patent claim on hepatitis C drug questioned in many countries

With hepatitis C killing at least 700,000 people every year, civil society has strengthened efforts to make the drug accessible

Call to make healthy choices available and affordable

Health experts lash out at food industry for putting public health at risk

DTE Reportage

'Lifestyle' diseases spur UN to act

Time to wake up to threat of NCDs

As the UN begins its meeting to devise strategies to tackle NCDs, Indian public health activists say it was a wake-up call for the health …

Non-communicable diseases: The unrecognised public health threat

Health is rarely the topic of discussion at the UN general assembly. But starting September 19, the UN began a high-level meeting to debate a …

After India, China rejects patent claim for hepatitis C drug Sovaldi

Activists claim that the drug was developed using previously published information and an existing compound

Government withdraws NPPA’s power to fix prices of non-essential medicines

Prices of cardiac, diabetes, HIV/AIDS drugs likely to be affected

Drug pricing policies bent to favour pharma industry, allege health experts

Nearly 83 per cent medicines out of the ambit of price control policy, thus making them out of reach for most patients, say two recent reports